BK

Bipin Kumar Srivastava

Active Director Director DIN 07636927
DIN 07636927 First appointment Apr 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 2015
Shareholding value •••• Premium profile

About Bipin Kumar Srivastava

Data last updated:

Bipin Kumar Srivastava is a Director at Ramans Healthcare And Diagnostics Private Limited (since 2017), Director at Dev Institute Of Nuclear Medicine Private Limited (since 2015) and Director at Asrb Medical Services Private Limited (since 2018), and holds 1 more current directorship. The companies operate in Healthcare and Engineering. The 3 current companies with reported revenue have a combined latest revenue of ₹14.37 Cr; the largest is Ramans Healthcare And Diagnostics Private Limited at ₹8.56 Cr (FY 2024). Earlier, Bipin Kumar Srivastava was a Director at Raman Imaging And Diagnostic Private Limited (2020–2021).

DIN 07636927
Primary Designation Director
Industry Healthcare
First Appointment 12 Apr 2015
Oldest Company Age 22 yrs
Largest company Ramans Healthcare And Diagnostics Private Limited · ₹8.56 Cr (FY 2024)
Combined revenue ₹14.37 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Oct 20172017₹8.56 Cr (FY 2024)Active
Director12 Apr 20152004₹5.79 Cr (FY 2021)Active
Director17 Feb 20182018₹1.9 Lakh (FY 2025)Active
Designated Partner08 Mar 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Dec 20202020₹7.03 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dev Institute Of Nuclear Medicine Private Limited
Asrb Medical Services Private Limited
Ramans Healthcare And Diagnostics Private Limited
Nuclear Imaging And Therapy Llp
Premium access

Shareholding and investment profile for Bipin Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bipin Kumar Srivastava

Bipin Kumar Srivastava currently holds 4 directorships: Ramans Healthcare And Diagnostics Private Limited (Director, since 05 Oct 2017, revenue ₹8.56 Cr (FY 2024)); Dev Institute Of Nuclear Medicine Private Limited (Director, since 12 Apr 2015, revenue ₹5.79 Cr (FY 2021)); Asrb Medical Services Private Limited (Director, since 17 Feb 2018, revenue ₹1.9 Lakh (FY 2025)); Nuclear Imaging And Therapy Llp (Designated Partner, since 08 Mar 2019).

Bipin Kumar Srivastava was first appointed on 12 Apr 2015 as Director at Dev Institute Of Nuclear Medicine Private Limited. The most recent appointment on record is 16 Dec 2020 at Raman Imaging And Diagnostic Private Limited.

The 3 current companies of Bipin Kumar Srivastava that report revenue have a combined latest revenue of ₹14.37 Cr: Ramans Healthcare And Diagnostics Private Limited ₹8.56 Cr (FY 2024); Dev Institute Of Nuclear Medicine Private Limited ₹5.79 Cr (FY 2021); Asrb Medical Services Private Limited ₹1.9 Lakh (FY 2025).

Bipin Kumar Srivastava held 1 earlier board appointment: Raman Imaging And Diagnostic Private Limited (Director, 16 Dec 2020 to 24 Nov 2021).

The current boards of Bipin Kumar Srivastava's companies include Sangeeta Srivastva (Ramans Healthcare And Diagnostics Private Limited), Girish Kumar Srivastava (Dev Institute Of Nuclear Medicine Private Limited), Ravi Shankar Kumar (Dev Institute Of Nuclear Medicine Private Limited), Vihag Raman (Dev Institute Of Nuclear Medicine Private Limited), Riya Kumar (Asrb Medical Services Private Limited), Ram Narayan Singh (Nuclear Imaging And Therapy Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available